Related Experiment Video
Updated: Nov 22, 2025

08:01
The Soft Agar Colony Formation Assay
Published on: October 27, 2014
113.0K
Wnt5a Plays Controversial Roles in Cancer Progression
Xu Chen1, Hong Ling Liu2, Feng Hui Zhao1
1Department of Pathology, Gansu Provincial Hospital, Lanzhou 730000, China.
Summary
Wnt5a protein is crucial for cancer progression, influencing invasion and migration. Its complex role in cancer, involving epigenetic changes and various pathways, makes it a potential biomarker for treatment and prognosis.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Wnt5a is a key Wnt ligand regulating cellular functions via the non-classical Wnt pathway.
- The role of Wnt5a in cancer is complex and not fully understood, potentially influenced by epigenetic modifications and alternative mRNA splicing.
- Wnt5a signaling is implicated in various pathological conditions, highlighting its significance in disease.
Purpose of the Study:
- To elucidate the multifaceted role of Wnt5a in cancer progression.
- To investigate the potential of Wnt5a as a prognostic and therapeutic biomarker in oncology.
- To explore the regulatory mechanisms, including epigenetic modifications and mRNA isoforms, that influence Wnt5a's function in cancer.
Main Methods:
- Analysis of Wnt5a expression patterns in cancer tissues.
- Investigation of Wnt5a downstream signaling pathways.
- Assessment of the impact of Wnt5a modulation on cancer cell behaviors like invasion, migration, and epithelial-mesenchymal transition (EMT).
- Exploration of epigenetic modifications (e.g., methylation) affecting Wnt5a.
Main Results:
- Wnt5a is identified as an essential factor driving cancer progression, including invasion, migration, proliferation, and EMT.
- Evidence suggests that epigenetic modifications and distinct mRNA isoforms contribute to Wnt5a's varied roles in cancer.
- The non-classical Wnt5a pathway plays a significant role in mediating these pro-cancerous effects.
Conclusions:
- Wnt5a is a critical mediator of cancer progression through multiple cellular mechanisms.
- Understanding the regulatory nuances of Wnt5a, including epigenetic factors, is vital for cancer therapy.
- Wnt5a presents a promising biomarker for predicting cancer prognosis and guiding treatment strategies.
Related Concept Videos
Canonical Wnt Signaling Pathway
9.8K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.8K
Non-Canonical Wnt Signaling Pathways
8.0K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.0K
Tumor Progression
6.9K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.9K
mTOR Signaling and Cancer Progression
4.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.1K
Adaptive Mechanisms in Cancer Cells
6.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.2K

